Share on StockTwits
 

Equities researchers at JPMorgan Chase & Co. hoisted their price target on shares of Croda International Plc (LON:CRDA) from GBX 2,350 ($39.08) to GBX 2,400 ($39.91) in a research report issued on Wednesday, Stock Ratings Network.com reports. The firm currently has a “neutral” rating on the stock. JPMorgan Chase & Co.’s price target would indicate a potential downside of 4.95% from the stock’s previous close.

Several other analysts have also recently commented on the stock. Analysts at Barclays reiterated an “equal weight” rating on shares of Croda International Plc in a research note on Wednesday. They now have a GBX 2,600 ($43.24) price target on the stock. Separately, analysts at Citigroup Inc. reiterated a “sell” rating on shares of Croda International Plc in a research note on Wednesday. They now have a GBX 2,100 ($34.92) price target on the stock. Finally, analysts at Credit Suisse reiterated an “outperform” rating on shares of Croda International Plc in a research note on Tuesday. They now have a GBX 2,850 ($47.40) price target on the stock. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and twelve have assigned a buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of GBX 2,672.62 ($44.45).

Croda International Plc (LON:CRDA) traded down 0.51% on Wednesday, hitting GBX 2525.00. 237,576 shares of the company’s stock traded hands. Croda International Plc has a 52 week low of GBX 2205.00 and a 52 week high of GBX 2846.00. The stock has a 50-day moving average of GBX 2429.42 and a 200-day moving average of GBX 2483.. The company’s market cap is £3.411 billion.

The company also recently declared a dividend, which is scheduled for Friday, May 30th. Investors of record on Wednesday, April 30th will be given a dividend of GBX 35.50 ($0.59) per share. This represents a yield of 1.39%. The ex-dividend date of this dividend is Wednesday, April 30th.

Croda International Plc is a marketing and technology company that produces and sells speciality chemicals.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.